CAGNETTA, ANTONIA
CAGNETTA, ANTONIA
A Blastic Plasmacytoid Dendritic Cell Neoplasm-like Phenotype Identifies a Subgroup of NPM1-Mutated AML Patients with Worse Prognosis While Has Not Predictive Value in NPM1-Wt AML
2018-01-01 Guolo, Fabio; Minetto, Paola; Kunkl, Annalisa; Tedone, Elisabetta; Clavio, Marino; Miglino, Maurizio; Caviglia, Fabrizio; Colombo, Nicoletta; Cagnetta, Antonia; Cea, Michele; Ballerini, Filippo; Ravetti, Jean Louis; Gobbi, Marco; Lemoli, Roberto Massimo
A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia
2019-01-01 Marcolin, R.; Guolo, F.; Minetto, P.; Clavio, M.; Manconi, L.; Ballerini, F.; Carli, A.; Passannante, Monica; Colombo, N.; Carminati, E.; Pugliese, Girolamo; Tedone, E.; Contini, P.; Mangerini, R.; Kunkl, A.; Miglino, M.; Cagnetta, A.; Cea, M.; Gobbi, M.; Lemoli, R. M.
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib
2010-01-01 Cea, Michele; Cirmena, Gabriella; Garuti, Anna; Rocco, Ilaria; Palermo, Claudia; Cagnetta, Antonia; Moran, Eva; Colombo, Nicoletta; Grasso, Raffaella; Fugazza, Giuseppina; Gobbi, Marco; Nencioni, Alessio; Ballestrero, Alberto; Patrone, Franco
Amino acid depletion triggered by L-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell death
2020-01-01 Soncini, D.; Minetto, P.; Martinuzzi, C.; Becherini, P.; Fenu, V.; Guolo, F.; Todoerti, K.; Calice, G.; Contini, P.; Miglino, M.; Rivoli, G.; Aquino, S.; Dominietto, A.; Cagnetta, A.; Passalacqua, M.; Bruzzone, S.; Nencioni, A.; Zucchetti, M.; Ceruti, T.; Neri, A.; Lemoli, R. M.; Cea, M.
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS
2009-01-01 Cea, Mc; Cagnetta, Antonia; Garuti, Anna; Zoppoli, Gabriele; Rocco, Ilaria; Moran, Eva; Ballestrero, Alberto; Pierri, Ivana; Gobbi, Marco; Nencioni, Alessio; Patrone, Franco
APO866 activity in hematologic malignancies: a preclinical in vitro study.
2009-01-01 Cea, Michele; Zoppoli, Gabriele; Bruzzone, Santina; Fruscione, Floriana; Moran, Eva; Garuti, Anna; Rocco, Ilaria; Cirmena, Gabriella; Casciaro, S; Olcese, F; Pierri, Ivana; Cagnetta, Antonia; Ferrando, Fabio; Ghio, Riccardo; Gobbi, Marco; Ballestrero, Alberto; Patrone, Franco; Nencioni, Alessio
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells
2015-01-01 Cagnetta, Antonia; Caffa, Irene; Acharya, Chirag; Soncini, Debora; Acharya, Prakrati; Adamia, Sophia; Pierri, Ivana; Bergamaschi, Micaela; Garuti, Anna; Fraternali, Giulio; Mastracci, Luca; Provenzani, Alessandro; Zucal, Chiara; Damonte, Gianluca; Salis, Annalisa; Montecucco, Fabrizio; Patrone, Franco; Ballestrero, Alberto; Bruzzone, Santina; Gobbi, Marco; Nencioni, Alessio; Cea, Michele
APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment
2016-01-01 Tai, Yu Tzu; Acharya, Chirag; An, Gang; Moschetta, Michele; Zhong, Mike Y; Feng, Xiaoyan; Cea, Michele; Cagnetta, Antonia; Wen, Kenneth; van Eenennaam, Hans; van Elsas, Andrea; Qiu, Lugui; Richardson, Paul; Munshi, Nikhil; Anderson, Kenneth C.
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma
2012-01-01 Tai, Yu Tzu; Chang, Betty Y.; Kong, Sun Young; Fulciniti, Mariateresa; Yang, Guang; Calle, Yolanda; Hu, Yiguo; Lin, Jianhong; Zhao, Jian Jun; Cagnetta, Antonia; Cea, Michele; Sellitto, Michael A.; Zhong, Mike Y.; Wang, Qiuju; Acharya, Chirag; Carrasco, Daniel R.; Buggy, Joseph J.; Elias, Laurence; Treon, Steven P.; Matsui, William; Richardson, Paul; Munshi, Nikhil C.; Anderson, Kenneth C.
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents
2023-01-01 Becherini, Pamela; Soncini, Debora; Ravera, Silvia; Gelli, Elisa; Martinuzzi, Claudia; Giorgetti, Giulia; Cagnetta, Antonia; Guolo, Fabio; Ivaldi, Federico; Miglino, Maurizio; Aquino, Sara; Todoerti, Katia; Neri, Antonino; Benzi, Andrea; Passalacqua, Mario; Nencioni, Alessio; Perrotta, Ida; Eugenia Gallo Cantafio, Maria; Amodio, Nicola; DE FLORA, Antonio; Bruzzone, Santina; Lemoli, Roberto M.; Cea, Michele
CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: Molecular mechanisms and therapeutic implications
2014-01-01 Tai, Y. T; Landesman, Y.; Acharya, C.; Calle, Y.; Zhong, M. Y.; Cea, Michele; Tannenbaum, D.; Cagnetta, Antonia; Reagan, M.; Munshi, A. A.; Senapedis, W.; Saint Martin, J. R.; Kashyap, T.; Shacham, S.; Kauffman, M.; Gu, Y.; Wu, L.; Ghobrial, I.; Zhan, F.; Kung, A. L.; Schey, S. A.; Richardson, P.; Munshi, N. C.; Anderson, K. C.
Daratumumab in the treatment of C3 glomerulopathy with monoclonal gammopathy: a case report and literature review
2023-01-01 Esposito, P.; Picciotto, D.; Costigliolo, F.; Russo, E.; Macciò, L.; Cenacchi, G.; Cagnetta, A.; Cea, M.; Lemoli, R. M.; Viazzi, F.
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells vulnerability to DNA-damaging agents
2018-01-01 Cagnetta, Antonia; Soncini, Debora; Orecchioni, Stefania; Talarico, Giovanna; Minetto, Paola; Guolo, Fabio; Retali, Veronica; Colombo, Nicoletta; Carminati, Enrico; Clavio, Marino; Miglino, Maurizio; Bergamaschi, Micaela; Nahimana, Aimable; Duchosal, Michael; Todoerti, Katia; Neri, Antonino; Passalacqua, Mario; Bruzzone, Santina; Nencioni, Alessio; Bertolini, Francesco; Gobbi, Marco; Lemoli, Roberto M; Cea, Michele
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas
2020-01-01 Manconi, Lorenzo; Coviello, Elisa; Canale, Filippo; Giannoni, Livia; Minetto, Paola; Guolo, Fabio; Clavio, Marino; Marcolin, Riccardo; Cea, Michele; Cagnetta, Antonia; Gobbi, Marco; Miglino, Maurizio; Ballerini, Filippo; Lemoli, Roberto Massimo
Dual NAMPT and BTK targeting leads to synergistic killing of Waldenström macroglobulinemia cells regardless of MYD88 and CXCR4 somatic mutation status
2016-01-01 Cea, M.; Cagnetta, A.; Acharya, C.; Acharya, P.; Tai, Y. -T.; Yang, C.; Lovera, D.; Soncini, D.; Miglino, M.; Fraternali-Orcioni, G.; Mastracci, L.; Nencioni, A.; Montecucco, F.; Monacelli, F.; Ballestrero, A.; Hideshima, T.; Chauhan, D.; Gobbi, M.; Lemoli, R. M.; Munshi, N.; Treon, S. P.; Anderson, K. C.
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information
2018-01-01 Minetto, Paola; Guolo, Fabio; Clavio, Marino; Kunkl, Annalisa; Colombo, Nicoletta; Carminati, Enrico; Fugazza, Giuseppina; Matarese, Simona; Guardo, Daniela; Ballerini, Filippo; Di Grazia, Carmen; Raiola, Anna M.; Cagnetta, Antonia; Cea, Michele; Miglino, Maurizio; Lemoli, ROBERTO MASSIMO; Gobbi, Marco
Evaluating treatment response of chronic myeloid leukemia: emerging science and technology.
2013-01-01 Cagnetta, Antonia; Garuti, A; Marani, C; Cea, Michele; Miglino, Maurizio; Rocco, I; Palermo, C; Fugazza, G; Cirmena, Gabriella; Colombo, Nicoletta; Grasso, R; Nencioni, Alessio; Gobbi, Marco; Patrone, F.
Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells
2016-01-01 Cea, M.; Cagnetta, A.; Adamia, S.; Acharya, C.; Tai, Y. -T.; Fulciniti, M.; Ohguchi, H.; Munshi, A.; Acharya, P.; Bhasin, M. K.; Zhong, L.; Carrasco, R.; Monacelli, F.; Ballestrero, A.; Richardson, P.; Gobbi, M.; Lemoli, R. M.; Munshi, N.; Hideshima, T.; Nencioni, A.; Chauhan, D.; Anderson, K. C.
Exploiting tumor vulnerabilities: NAD+-depleting agents combined with anti-tumor drugs as innovative strategy to treat hematological malignancies
2016-01-01 Cea, Michele; Soncini, Debora; Gobbi, Marco; Lemoli, ROBERTO MASSIMO; Cagnetta, Antonia
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION
2010-01-01 Cea, Michele; Cagnetta, Antonia; Garuti, Anna; Cirmena, Gabriella; Rocco, Ilaria; Palermo, Claudia; Soncini, Debora; Caffa, Irene; Zoppoli, Gabriele; Pierri, Ivana; Gobbi, Marco; Ballestrero, Alberto; Nencioni, Alessio; Patrone, Franco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Blastic Plasmacytoid Dendritic Cell Neoplasm-like Phenotype Identifies a Subgroup of NPM1-Mutated AML Patients with Worse Prognosis While Has Not Predictive Value in NPM1-Wt AML | 1-gen-2018 | Guolo, Fabio; Minetto, Paola; Kunkl, Annalisa; Tedone, Elisabetta; Clavio, Marino; Miglino, Maurizio; Caviglia, Fabrizio; Colombo, Nicoletta; Cagnetta, Antonia; Cea, Michele; Ballerini, Filippo; Ravetti, Jean Louis; Gobbi, Marco; Lemoli, Roberto Massimo | |
| A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia | 1-gen-2019 | Marcolin, R.; Guolo, F.; Minetto, P.; Clavio, M.; Manconi, L.; Ballerini, F.; Carli, A.; Passannante, Monica; Colombo, N.; Carminati, E.; Pugliese, Girolamo; Tedone, E.; Contini, P.; Mangerini, R.; Kunkl, A.; Miglino, M.; Cagnetta, A.; Cea, M.; Gobbi, M.; Lemoli, R. M. | |
| A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib | 1-gen-2010 | Cea, Michele; Cirmena, Gabriella; Garuti, Anna; Rocco, Ilaria; Palermo, Claudia; Cagnetta, Antonia; Moran, Eva; Colombo, Nicoletta; Grasso, Raffaella; Fugazza, Giuseppina; Gobbi, Marco; Nencioni, Alessio; Ballestrero, Alberto; Patrone, Franco | |
| Amino acid depletion triggered by L-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell death | 1-gen-2020 | Soncini, D.; Minetto, P.; Martinuzzi, C.; Becherini, P.; Fenu, V.; Guolo, F.; Todoerti, K.; Calice, G.; Contini, P.; Miglino, M.; Rivoli, G.; Aquino, S.; Dominietto, A.; Cagnetta, A.; Passalacqua, M.; Bruzzone, S.; Nencioni, A.; Zucchetti, M.; Ceruti, T.; Neri, A.; Lemoli, R. M.; Cea, M. | |
| ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS | 1-gen-2009 | Cea, Mc; Cagnetta, Antonia; Garuti, Anna; Zoppoli, Gabriele; Rocco, Ilaria; Moran, Eva; Ballestrero, Alberto; Pierri, Ivana; Gobbi, Marco; Nencioni, Alessio; Patrone, Franco | |
| APO866 activity in hematologic malignancies: a preclinical in vitro study. | 1-gen-2009 | Cea, Michele; Zoppoli, Gabriele; Bruzzone, Santina; Fruscione, Floriana; Moran, Eva; Garuti, Anna; Rocco, Ilaria; Cirmena, Gabriella; Casciaro, S; Olcese, F; Pierri, Ivana; Cagnetta, Antonia; Ferrando, Fabio; Ghio, Riccardo; Gobbi, Marco; Ballestrero, Alberto; Patrone, Franco; Nencioni, Alessio | |
| APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells | 1-gen-2015 | Cagnetta, Antonia; Caffa, Irene; Acharya, Chirag; Soncini, Debora; Acharya, Prakrati; Adamia, Sophia; Pierri, Ivana; Bergamaschi, Micaela; Garuti, Anna; Fraternali, Giulio; Mastracci, Luca; Provenzani, Alessandro; Zucal, Chiara; Damonte, Gianluca; Salis, Annalisa; Montecucco, Fabrizio; Patrone, Franco; Ballestrero, Alberto; Bruzzone, Santina; Gobbi, Marco; Nencioni, Alessio; Cea, Michele | |
| APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment | 1-gen-2016 | Tai, Yu Tzu; Acharya, Chirag; An, Gang; Moschetta, Michele; Zhong, Mike Y; Feng, Xiaoyan; Cea, Michele; Cagnetta, Antonia; Wen, Kenneth; van Eenennaam, Hans; van Elsas, Andrea; Qiu, Lugui; Richardson, Paul; Munshi, Nikhil; Anderson, Kenneth C. | |
| Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma | 1-gen-2012 | Tai, Yu Tzu; Chang, Betty Y.; Kong, Sun Young; Fulciniti, Mariateresa; Yang, Guang; Calle, Yolanda; Hu, Yiguo; Lin, Jianhong; Zhao, Jian Jun; Cagnetta, Antonia; Cea, Michele; Sellitto, Michael A.; Zhong, Mike Y.; Wang, Qiuju; Acharya, Chirag; Carrasco, Daniel R.; Buggy, Joseph J.; Elias, Laurence; Treon, Steven P.; Matsui, William; Richardson, Paul; Munshi, Nikhil C.; Anderson, Kenneth C. | |
| CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents | 1-gen-2023 | Becherini, Pamela; Soncini, Debora; Ravera, Silvia; Gelli, Elisa; Martinuzzi, Claudia; Giorgetti, Giulia; Cagnetta, Antonia; Guolo, Fabio; Ivaldi, Federico; Miglino, Maurizio; Aquino, Sara; Todoerti, Katia; Neri, Antonino; Benzi, Andrea; Passalacqua, Mario; Nencioni, Alessio; Perrotta, Ida; Eugenia Gallo Cantafio, Maria; Amodio, Nicola; DE FLORA, Antonio; Bruzzone, Santina; Lemoli, Roberto M.; Cea, Michele | |
| CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: Molecular mechanisms and therapeutic implications | 1-gen-2014 | Tai, Y. T; Landesman, Y.; Acharya, C.; Calle, Y.; Zhong, M. Y.; Cea, Michele; Tannenbaum, D.; Cagnetta, Antonia; Reagan, M.; Munshi, A. A.; Senapedis, W.; Saint Martin, J. R.; Kashyap, T.; Shacham, S.; Kauffman, M.; Gu, Y.; Wu, L.; Ghobrial, I.; Zhan, F.; Kung, A. L.; Schey, S. A.; Richardson, P.; Munshi, N. C.; Anderson, K. C. | |
| Daratumumab in the treatment of C3 glomerulopathy with monoclonal gammopathy: a case report and literature review | 1-gen-2023 | Esposito, P.; Picciotto, D.; Costigliolo, F.; Russo, E.; Macciò, L.; Cenacchi, G.; Cagnetta, A.; Cea, M.; Lemoli, R. M.; Viazzi, F. | |
| Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells vulnerability to DNA-damaging agents | 1-gen-2018 | Cagnetta, Antonia; Soncini, Debora; Orecchioni, Stefania; Talarico, Giovanna; Minetto, Paola; Guolo, Fabio; Retali, Veronica; Colombo, Nicoletta; Carminati, Enrico; Clavio, Marino; Miglino, Maurizio; Bergamaschi, Micaela; Nahimana, Aimable; Duchosal, Michael; Todoerti, Katia; Neri, Antonino; Passalacqua, Mario; Bruzzone, Santina; Nencioni, Alessio; Bertolini, Francesco; Gobbi, Marco; Lemoli, Roberto M; Cea, Michele | |
| Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas | 1-gen-2020 | Manconi, Lorenzo; Coviello, Elisa; Canale, Filippo; Giannoni, Livia; Minetto, Paola; Guolo, Fabio; Clavio, Marino; Marcolin, Riccardo; Cea, Michele; Cagnetta, Antonia; Gobbi, Marco; Miglino, Maurizio; Ballerini, Filippo; Lemoli, Roberto Massimo | |
| Dual NAMPT and BTK targeting leads to synergistic killing of Waldenström macroglobulinemia cells regardless of MYD88 and CXCR4 somatic mutation status | 1-gen-2016 | Cea, M.; Cagnetta, A.; Acharya, C.; Acharya, P.; Tai, Y. -T.; Yang, C.; Lovera, D.; Soncini, D.; Miglino, M.; Fraternali-Orcioni, G.; Mastracci, L.; Nencioni, A.; Montecucco, F.; Monacelli, F.; Ballestrero, A.; Hideshima, T.; Chauhan, D.; Gobbi, M.; Lemoli, R. M.; Munshi, N.; Treon, S. P.; Anderson, K. C. | |
| Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information | 1-gen-2018 | Minetto, Paola; Guolo, Fabio; Clavio, Marino; Kunkl, Annalisa; Colombo, Nicoletta; Carminati, Enrico; Fugazza, Giuseppina; Matarese, Simona; Guardo, Daniela; Ballerini, Filippo; Di Grazia, Carmen; Raiola, Anna M.; Cagnetta, Antonia; Cea, Michele; Miglino, Maurizio; Lemoli, ROBERTO MASSIMO; Gobbi, Marco | |
| Evaluating treatment response of chronic myeloid leukemia: emerging science and technology. | 1-gen-2013 | Cagnetta, Antonia; Garuti, A; Marani, C; Cea, Michele; Miglino, Maurizio; Rocco, I; Palermo, C; Fugazza, G; Cirmena, Gabriella; Colombo, Nicoletta; Grasso, R; Nencioni, Alessio; Gobbi, Marco; Patrone, F. | |
| Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells | 1-gen-2016 | Cea, M.; Cagnetta, A.; Adamia, S.; Acharya, C.; Tai, Y. -T.; Fulciniti, M.; Ohguchi, H.; Munshi, A.; Acharya, P.; Bhasin, M. K.; Zhong, L.; Carrasco, R.; Monacelli, F.; Ballestrero, A.; Richardson, P.; Gobbi, M.; Lemoli, R. M.; Munshi, N.; Hideshima, T.; Nencioni, A.; Chauhan, D.; Anderson, K. C. | |
| Exploiting tumor vulnerabilities: NAD+-depleting agents combined with anti-tumor drugs as innovative strategy to treat hematological malignancies | 1-gen-2016 | Cea, Michele; Soncini, Debora; Gobbi, Marco; Lemoli, ROBERTO MASSIMO; Cagnetta, Antonia | |
| HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION | 1-gen-2010 | Cea, Michele; Cagnetta, Antonia; Garuti, Anna; Cirmena, Gabriella; Rocco, Ilaria; Palermo, Claudia; Soncini, Debora; Caffa, Irene; Zoppoli, Gabriele; Pierri, Ivana; Gobbi, Marco; Ballestrero, Alberto; Nencioni, Alessio; Patrone, Franco |